After three and a half years on intravenous immune globulin, or IVIG, to treat her multiple sclerosis, insurance is no longer paying for Simone Biase's therapy. "It's costing about $4000 dollars a month," said the IVIG patient.
msactivist.blogspot.com/2007/11/insurance-stops-covering-intravenous.html